M D Sullivan1, B M Heywood, D R Beukelman. 1. Department of Speech/Language Pathology, Munroe-Meyer Institute, Omaha, NE 68198-5450, USA. mdsulliv@unmc.edu
Abstract
OBJECTIVES: This article reports the outcome of a speech pathology treatment program for vocal cord dysfunction (VCD) in 20 adolescent female athletes. STUDY DESIGN: A retrospective, nonrandomized group design was used to collect the outcome data. METHODS: Twenty consecutive referrals of female athletes diagnosed as having symptoms of VCD during exercise were assessed, treated, and followed for at least 6 months after treatment. RESULTS: Ninety-five percent of the participants reported the ability to control symptoms of VCD during exercise up to 6 months after treatment. Asthma medications were no longer used by 80% of the athletes. All of the females continued to participate in athletics. CONCLUSION: Speech pathology intervention focusing on respiratory control of VCD in adolescent female athletes is an effective treatment resulting in the athletes' ability to control the symptoms of VCD in exercise for at least 6 months after treatment.
OBJECTIVES: This article reports the outcome of a speech pathology treatment program for vocal cord dysfunction (VCD) in 20 adolescent female athletes. STUDY DESIGN: A retrospective, nonrandomized group design was used to collect the outcome data. METHODS: Twenty consecutive referrals of female athletes diagnosed as having symptoms of VCD during exercise were assessed, treated, and followed for at least 6 months after treatment. RESULTS: Ninety-five percent of the participants reported the ability to control symptoms of VCD during exercise up to 6 months after treatment. Asthma medications were no longer used by 80% of the athletes. All of the females continued to participate in athletics. CONCLUSION: Speech pathology intervention focusing on respiratory control of VCD in adolescent female athletes is an effective treatment resulting in the athletes' ability to control the symptoms of VCD in exercise for at least 6 months after treatment.
Authors: Robert C Maat; Ola D Roksund; Jan Olofsson; Thomas Halvorsen; Britt T Skadberg; John-Helge Heimdal Journal: Eur Arch Otorhinolaryngol Date: 2007-01-04 Impact factor: 2.503